According to a newly published market research report by 24LifeSciences, global PD-1 and PD-L1 monoclonal antibody market was valued at USD 32.6 billion in 2025 and is projected to reach USD 63.4 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.7% during the forecast period 2026–2034. PD-1/PD-L1 monoclonal antibodies represent a groundbreaking class of...

The lymphoma treatment market is witnessing significant growth as healthcare providers increasingly focus on improving outcomes for patients diagnosed with Hodgkin lymphoma and non-Hodgkin lymphoma. Rising cancer prevalence, advancements in oncology research, and the growing adoption of innovative treatment approaches are contributing to the expansion of the market. The development of targeted...